DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Brainstorm Cell Therapeutics Inc. (BCLI)
« Back to company indexBCLI Chatter Timeline
Stock Ticker for BCLI
Most Active Tweeters for BCLI
| User | Tweets |
|---|---|
| @bulletin_en | 3 |
| @whatsonthorold2 | 3 |
| @thefinreviewer | 3 |
| @AmericanBanking | 3 |
| @StockTexts | 3 |
Recent Tweets for BCLI
 |
@tzack16 $BCLI Early Access to ALS Treatment in Israel https://t.co/aiHcylLIZa $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/0UhPpGfwu0 March 21st 2019, 7:03pm |
 |
@UlmHi Reviewing Pain Therapeutics Inc. $BCLI's results https://t.co/Mfa11JXbHj March 21st 2019, 1:03pm |
 |
@TheTruthStudio $BCLI Early Access to ALS Treatment in Israel https://t.co/Y3tTXGH6Ec $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/poxFzuVyUe March 20th 2019, 11:03pm |
 |
@zackcapp $BCLI Early Access to ALS Treatment in Israel https://t.co/WZNWim4GXh $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/5ADgshs1ap March 20th 2019, 5:03pm |
 |
@InstitutionalZC $BCLI Early Access to ALS Treatment in Israel https://t.co/cEjEG1w0kc $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/PISKBdKfjl March 20th 2019, 3:03pm |
 |
@bbnsnews -$0.10 Earnings Per Share Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/SaOc2wUjtD March 20th 2019, 12:03pm |
 |
@stocknewstimes Critical Comparison: Brainstorm Cell Therapeutics $BCLI and Atara Biotherapeutics $ATRA https://t.co/WfFNKBuOr3 March 20th 2019, 10:03am |
 |
@TheMarketsDaily Head to Head Review: Brainstorm Cell Therapeutics $BCLI & Atara Biotherapeutics $ATRA https://t.co/ISx4D7lsXh March 20th 2019, 10:03am |
 |
@AmericanBanking Head to Head Review: Brainstorm Cell Therapeutics $BCLI & Atara Biotherapeutics $ATRA https://t.co/E55uMTGEzX #stocks March 20th 2019, 10:03am |
 |
@AnalystsAnalyst $BCLI Early Access to ALS Treatment in Israel https://t.co/E07oz8kD0y $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/casigKuS78 March 20th 2019, 9:03am |
 |
@ahighelevation $BCLI Early Access to ALS Treatment in Israel https://t.co/q80lgiDiQm $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/DCJguA48sZ March 20th 2019, 12:03am |
 |
@thefinreviewer Reviewing Unity Biotechnology Inc. $BCLI's results https://t.co/ZAMBdJetBt March 19th 2019, 8:03pm |
 |
@zackcappsocial $BCLI Early Access to ALS Treatment in Israel https://t.co/oDS6zl7m4A $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/dPnsYqb3Ku March 19th 2019, 7:03pm |
 |
@ContentCarnivor $BCLI Early Access to ALS Treatment in Israel https://t.co/ftme5xtvyV $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/BHWfL6J3ql March 19th 2019, 6:03pm |
 |
@BlogYomi Comparing of Millendo Therapeutics Inc. $BCLI https://t.co/sDWkfJSCXu March 19th 2019, 6:03pm |
 |
@ZacksAwareness $BCLI Early Access to ALS Treatment in Israel https://t.co/CbYaca91a6 $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/Dq4UdCOBGF March 19th 2019, 6:03pm |
 |
@HowieRegay $BCLI Early Access to ALS Treatment in Israel https://t.co/pD18tCcpKy $BCLI @BrainstormCell #biotech @davidbautz… https://t.co/CIvuZdkSer March 19th 2019, 3:03pm |
|
@stocknewstimes $1.50 Million in Sales Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/jpqBHhHnUK March 19th 2019, 3:03am |
|
@AmericanBanking $1.50 Million in Sales Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/rsfnZiLiHf #stocks March 19th 2019, 3:03am |
 |
@TranscriptDaily $1.50 Million in Sales Expected for Brainstorm Cell Therapeutics Inc $BCLI This Quarter https://t.co/9HTRWhPK2I March 19th 2019, 3:03am |
|
@BlogYomi Comparing of Savara Inc. $BCLI https://t.co/q4jvoyBISa March 18th 2019, 8:03pm |
|
@thefinreviewer Reviewing Biohaven Pharmaceutical Holding Company Ltd. $BCLI's results https://t.co/yssd1yZ6hi March 18th 2019, 2:03am |
|
@AnalystsAnalyst $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/LqfOZyFj2Z $BCLI @BrainstormCell #biotech… https://t.co/fu6akd9ef6 March 17th 2019, 12:03pm |
|
@ZacksAwareness $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/N44PpDZteQ $BCLI @BrainstormCell #biotech… https://t.co/h24rjpqcbo March 17th 2019, 11:03am |
|
@HowieRegay $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/xmghV87coF $BCLI @BrainstormCell #biotech… https://t.co/npg5PYc0rc March 17th 2019, 11:03am |
|
@ContentCarnivor $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/tqDyizy40i $BCLI @BrainstormCell #biotech… https://t.co/7EqvY6x2ya March 17th 2019, 10:03am |
 |
@alsadvocacy Our arithmetic challenge... What is @BrainstormCell $BCLI thinking? Hmmm... Number of potential patients in appro… https://t.co/qP9wIjMYo7 March 17th 2019, 8:03am |
|
@TranscriptDaily Analysts Anticipate Brainstorm Cell Therapeutics Inc $BCLI to Announce -$0.10 Earnings Per Share https://t.co/OJOHAl5Rb3 March 17th 2019, 6:03am |
|
@AmericanBanking Analysts Anticipate Brainstorm Cell Therapeutics Inc $BCLI to Announce -$0.10 Earnings Per Share https://t.co/ym0l4hliwx #stocks March 17th 2019, 6:03am |
|
@ahighelevation $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/N8eXpy5ky4 $BCLI @BrainstormCell #biotech… https://t.co/Oi54SmZNbq March 17th 2019, 12:03am |
|
@zackcappsocial $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/cmV7iQRcuI $BCLI @BrainstormCell #biotech… https://t.co/tjRYuBalFu March 16th 2019, 10:03pm |
 |
@risk_averse_ $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/y24UtKD5cU $BCLI @BrainstormCell #biotech… https://t.co/HsphzjekwH March 16th 2019, 9:03pm |
|
@TheTruthStudio $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/xj8vlVZ3Jo $BCLI @BrainstormCell #biotech… https://t.co/ESq7jvMPHk March 16th 2019, 8:03pm |
|
@zackcapp $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/LKvI8Jjtmf $BCLI @BrainstormCell #biotech… https://t.co/bYUoUOeRbw March 16th 2019, 8:03pm |
|
@InstitutionalZC $BCLI Cell Therapy for Multiple Sclerosis in Phase 2 Trial https://t.co/asVoD4h685 $BCLI @BrainstormCell #biotech… https://t.co/M6BjMMopI3 March 16th 2019, 8:03pm |
 |
@ResearchPool $BCLI #Brainstorm Cell Therapeutics BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2… https://t.co/hkxg2MEOk3 March 15th 2019, 9:03pm |
 |
@ZacksSmallCap $BCLI: @BrainstormCell Early Access to ALS Treatment in Israel - https://t.co/VSe8y85PtT by @DavidBautz March 15th 2019, 10:03am |
 |
@MaisaCorp $BCLI Initiates Enrollment in Mid-Stage Trial of Progressive Multiple Sclerosis March 14th 2019, 4:03pm |
 |
@StockNewsNow $BCLI BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS https://t.co/grPICK8vxA March 14th 2019, 11:03am |
 |
@whatsonthorold2 What’s Propelling Brainstorm Cell Therapeutics Inc $BCLI After Lower Shorts Reported? https://t.co/WVez4rwH9S March 14th 2019, 9:03am |
 |
@bthefirsttoknow $BCLI BrainStorm Announces First Patient Enrolled in P..... https://t.co/6MzH7YvHX7 March 14th 2019, 2:03am |
 |
@newswithvalue $BCLI: BrainStorm Announces First Patient Enrolled in Phase 2 Clinical …: https://t.co/VajgyidloX March 14th 2019, 1:03am |
 |
@StockTexts $BCLI BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS Nasdaq:BCLI https://t.co/DtOSrNqHMB March 14th 2019, 1:03am |
 |
@mmahotstuff1 TOday’s Movers: Brainstorm Cell Therapeutics $BCLI Stock Rating Reaffirmed by Maxim Group; $9 Target Price Indicate… https://t.co/W6DD8cdJPd March 13th 2019, 10:03pm |
|
@whatsonthorold2 Analysts at Maxim Group Maintained their Past ‘"Buy"’ rating on Shares Brainstorm Cell Therapeutics $BCLI, Set a $9… https://t.co/ycy2hNAcFr March 13th 2019, 10:03pm |
 |
@bibeypost_stock Brainstorm Cell Therapeutics $BCLI: Maxim Group Reaffirms Buy Rating Today, Has a Target of $9/Share https://t.co/cGmxwDCX5L March 13th 2019, 10:03pm |
 |
@reurope_stock TOday’s Movers: Brainstorm Cell Therapeutics $BCLI Stock Rating Kept by Analysts at Maxim Group; $9 Target Price In… https://t.co/BUos97QeYC March 13th 2019, 10:03pm |
 |
@bulletin_en Brainstorm Cell Therapeutics Inc $BCLI Shorts Reduced By 1.09% https://t.co/NeCnvDJUjw March 13th 2019, 5:03pm |
|
@StockNewsNow $BCLI #VIDEO: BrainStorm Cell Therapeutics - Developing Cellular Therapies for Neurodegenerative Diseases… https://t.co/fF2apaOtoo March 13th 2019, 11:03am |
 |
@FinZTribune Anticipated $-0.13 EPS for Brainstorm Cell Therapeutics Inc. $BCLI as of March, 14 https://t.co/VvrVw3M4HZ March 13th 2019, 7:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.